Hans Van Vlierberghe

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Clinical Practice

Alcohol Consumption

Top Venues

Alimentary pharmacology & therapeutics

Case reports in infectious diseases

BMC research notes

This page only lists publications with an associated author ORCID identifier.

Publications

Roos Van Den Noortgate, Maja Kiselinova, Céline Sys, Geraldine P B M Accou, Guy Laureys, Hans Van Vlierberghe, Frederik Berrevoet, Elke O Kreps
Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody. Case reports in infectious diseases 2023 (2023)
Louise Magherman, Robbe Van Parys, Nele S Pauwels, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Sander Lefere
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Louise Magherman, Robbe Van Parys, Nele S Pauwels, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Sander Lefere
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Louise Magherman, Robbe Van Parys, Nele S Pauwels, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Sander Lefere
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stål, Debashis Sarker, Daniel H Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L Chan, Jennifer J Knox, Shukui Qin, Abby B Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S Finn, Andrew X Zhu
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Elisabeth Dhondt, Bieke Lambert, Laurens Hermie, Lynn Huyck, Peter Vanlangenhove, Anja Geerts, Xavier P D M J Verhelst, Maridi Aerts, Aude Vanlander, Frederik Berrevoet, Roberto Ivan Troisi, Hans Van Vlierberghe, Luc Defreyne
90 Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial. Radiology 303 (3) (2022)
Stijn Jeroen De Keukeleire, Tijl Vermassen, Zahra M Nezhad, Tessa Kerre, Vibeke Kruse, Hans Van Vlierberghe, Karim Vermaelen, Sylvie Rottey
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk? Immunotherapy 13 (5) (2021)
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 10 (11) (2021)
Sanne Van Campenhout, Agustina A M B Hastuti, Sander Lefere, Hans Van Vlierberghe, Frank Vanhaecke, Marta Costas-Rodríguez, Lindsey Devisscher
Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease. BMC research notes 13 (1) (2020)